COVID-19 Vaccine (Vaxzevria)

URI: https://gptkb.org/entity/COVID-19_Vaccine_(Vaxzevria)

GPTKB entity

Statements (49)

Predicate	Object
gptkbp:instanceOf	vaccine
gptkbp:administeredBy	adults 18 years and older
gptkbp:alsoKnownAs	gptkb:ChAdOx1_nCoV-19 gptkb:AZD1222 AstraZeneca COVID-19 Vaccine
gptkbp:approvedBy	gptkb:European_Union gptkb:United_Kingdom gptkb:World_Health_Organization December 2020
gptkbp:boosterRecommended	yes
gptkbp:category	gptkb:COVID-19_vaccines gptkb:World_Health_Organization_essential_medicines 2020 introductions AstraZeneca products Viral vector vaccines
gptkbp:contains	SARS-CoV-2 spike protein gene recombinant, replication-deficient chimpanzee adenovirus vector
gptkbp:countryOfOrigin	gptkb:United_Kingdom
gptkbp:developedBy	gptkb:AstraZeneca
gptkbp:dosingSchedule	two doses
gptkbp:efficacyAgainstSymptomaticCOVID19	~70%
gptkbp:emergencyServices	gptkb:World_Health_Organization
https://www.w3.org/2000/01/rdf-schema#label	COVID-19 Vaccine (Vaxzevria)
gptkbp:includedIn	COVAX initiative
gptkbp:indication	prevention of COVID-19
gptkbp:manufacturer	gptkb:SK_Bioscience gptkb:AstraZeneca gptkb:Serum_Institute_of_India gptkb:R-Pharm gptkb:Catalent gptkb:Fiocruz
gptkbp:notRecommendedFor	children under 18 people with history of severe allergic reaction to any component
gptkbp:rareAdverseEvent	thrombosis with thrombocytopenia syndrome
gptkbp:routeOfAdministration	intramuscular injection
gptkbp:sideEffect	fever nausea fatigue headache joint pain muscle pain chills
gptkbp:storage	2–8°C
gptkbp:target	gptkb:COVID-19
gptkbp:type	viral vector vaccine
gptkbp:vectorFor	gptkb:chimpanzee_adenovirus
gptkbp:WHOEmergencyUseListing	February 2021
gptkbp:bfsParent	gptkb:AstraZeneca_Group
gptkbp:bfsLayer	7